Evidence map›Paper›PMID 27458587›Full record

ArticleFrontiers in molecular biosciences2016

Feature Selection Methods for Early Predictive Biomarker Discovery Using Untargeted Metabolomic Data.

Dhouha Grissa, Mélanie Pétéra, Marion Brandolini, Amedeo Napoli, Blandine Comte, Estelle Pujos-Guillot

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Frontiers in molecular biosciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05238909 (Developing Novel Biomarkers of Plexiform Neurofibroma Tumor Burden), which is not on this map. Cited by 44 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 2 pooled it
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05238909 enrolling by invitationnot on this mapstarted 2022, after this paper: background citation

Developing Novel Biomarkers of Plexiform Neurofibroma Tumor Burden

Typeobservational_patient_registrySponsorAnn & Robert H Lurie Children's Hospital of ChicagoRan2022 to 2027Enrolled200ConditionsNeurofibromatosis 1, NF1, Neurofibromatosis Type 1
3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 2 syntheses or guidelines pooled it, 110 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Artificial Intelligence in Metabolomics: A Current Review.Trends in analytical chemistry : TRAC · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Dhouha GrissaINRA, UMR1019, UNH-MAPPING Clermont-Ferrand, France.
Mélanie PétéraINRA, UMR1019, Plateforme d'Exploration du Métabolisme Clermont-Ferrand, France.
Marion BrandoliniINRA, UMR1019, Plateforme d'Exploration du Métabolisme Clermont-Ferrand, France.
Amedeo NapoliLORIA Vandoeuvre-lès-Nancy, France.
Blandine ComteINRA, UMR1019, UNH-MAPPING Clermont-Ferrand, France.
Estelle Pujos-GuillotINRA, UMR1019, UNH-MAPPINGClermont-Ferrand, France; INRA, UMR1019, Plateforme d'Exploration du MétabolismeClermont-Ferrand, France.
Centre de Recherche en Nutrition Humaine d'Auvergne · FRInstitut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement · FRUnité de Nutrition Humaine · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Untargeted metabolomics is a powerful phenotyping tool for better understanding biological mechanisms involved in human pathology development and identifying early predictive biomarkers. This approach, based on multiple analytical platforms, such as mass spectrometry (MS), chemometrics and bioinformatics, generates massive and complex data that need appropriate analyses to extract the biologically meaningful information. Despite various tools available, it is still a challenge to handle such large and noisy datasets with limited number of individuals without risking overfitting. Moreover, when the objective is focused on the identification of early predictive markers of clinical outcome, few years before occurrence, it becomes essential to use the appropriate algorithms and workflow to be able to discover subtle effects among this large amount of data. In this context, this work consists in studying a workflow describing the general feature selection process, using knowledge discovery and data mining methodologies to propose advanced solutions for predictive biomarker discovery. The strategy was focused on evaluating a combination of numeric-symbolic approaches for feature selection with the objective of obtaining the best combination of metabolites producing an effective and accurate predictive model. Relying first on numerical approaches, and especially on machine learning methods (SVM-RFE, RF, RF-RFE) and on univariate statistical analyses (ANOVA), a comparative study was performed on an original metabolomic dataset and reduced subsets. As resampling method, LOOCV was applied to minimize the risk of overfitting. The best k-features obtained with different scores of importance from the combination of these different approaches were compared and allowed determining the variable stabilities using Formal Concept Analysis. The results revealed the interest of RF-Gini combined with ANOVA for feature selection as these two complementary methods allowed selecting the 48 best candidates for prediction. Using linear logistic regression on this reduced dataset enabled us to obtain the best performances in terms of prediction accuracy and number of false positive with a model including 5 top variables. Therefore, these results highlighted the interest of feature selection methods and the importance of working on reduced datasets for the identification of predictive biomarkers issued from untargeted metabolomics data.

Indexed as

biomarker discoveryfeature selectionformal concept analysismachine learningmetabolomicspredictionunivariate statisticsvisualization

Identifiers

PMID27458587
PMCPMC4937038
OpenAlexW2470233764

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.